
International Journal of Nanomedicine, Journal Year: 2024, Volume and Issue: Volume 19, P. 13113 - 13134
Published: Dec. 1, 2024
Phosphodiesterase-4 is an enzyme that regulates immune responses and contributes to the development of psoriasis. Dipyridamole roflumilast function as phosphodiesterase-4 inhibitors, reducing pro-inflammatory cytokine expression. The aim was evaluate anti-psoriatic effect topical administration dipyridamole nanoemulgel combination on imiquimod-induced psoriasiform skin inflammation in rats.
Language: Английский